How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Medical Toxicology Service Market
- By Service Type: Poison Control Center Services, Clinical Toxicology Consultation, Toxicology Testing and Analysis, Emergency Toxicology Services, Occupational Toxicology Assessment
- By End User: Hospitals and Healthcare Facilities, Pharmaceutical Companies, Government and Regulatory Agencies, Academic and Research Institutions, Occupational Health Clinics
- By Toxicology Type: Acute Toxicology, Chronic Toxicology, Pediatric Toxicology, Environmental Toxicology, Forensic Toxicology
- By Delivery Mode: In-person Consultation, Telemedicine Toxicology Services, On-site Toxicology Testing, Laboratory-based Toxicology Analysis
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Poison Control Center Services leads By Service Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.168 →
- 11 Company Profiles 15 players: SWOT & benchmarking p.176 →
Full report · locked preview
Everything inside the Medical Toxicology Service Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Service Type 5
End User 5
Toxicology Type 5
Delivery Mode 4
Companies profiled
Quest Diagnostics
LabCorp
BioReference Laboratories
Mayo Clinic Laboratories
ARUP Laboratories
Eurofins Scientific
Charles River Laboratories
ICON plc
PRA Health Sciences
Covance (Labcorp Drug Development)
Synexus
Alere Toxicology (Abbott)
+3 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Quest Diagnostics
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →LabCorp
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →BioReference Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mayo Clinic Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ARUP Laboratories
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Eurofins Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Charles River Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →ICON plc
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →PRA Health Sciences
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Covance (Labcorp Drug Development)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Synexus
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Alere Toxicology (Abbott)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Alere Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Abbott Laboratories
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Thermo Fisher Scientific
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$8,052M by 2033 · 6.3% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Poison Control Center Services40.6
- Clinical Toxicology Consultation12.4
- Toxicology Testing and Analysis12.9
- Emergency Toxicology Services13.0
- Occupational Toxicology Assessment21.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,632M → $2,904M · 7.5%
Europe$1,137M → $2,006M · 7.4%
Asia Pacific$1,038M → $1,670M · 6.1%
Latin America$642.8M → $1,084M · 6.7%
Middle East and Africa$494.5M → $748.0M · 5.3%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →6.242026
6.242027
6.262028
6.282029
6.292030
6.302031
6.312032
6.322033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Quest Diagnostics19.3
- LabCorp19.8
- BioReference Laboratories5.3
- Mayo Clinic Laboratories7.9
- ARUP Laboratories10.4
- Eurofins Scientific9.1
- Others28.2
Segment contribution to growth (%)
Fig. 18 · p.39 →Service Type20.1%
End User20.8%
Toxicology Type31.3%
Delivery Mode27.8%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.5
- Europe23.8
- Asia Pacific19.9
- Latin America12.9
- Middle East and Africa8.9
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics | 95 | 86 | 97 | 86 | 76 | 90 | 88 |
| LabCorp | 79 | 90 | 87 | 78 | 77 | 92 | 84 |
| BioReference Laboratories | 81 | 64 | 81 | 71 | 68 | 81 | 74 |
| Mayo Clinic Laboratories | 57 | 67 | 57 | 73 | 61 | 74 | 65 |
| ARUP Laboratories | 63 | 69 | 60 | 74 | 63 | 75 | 67 |
| Eurofins Scientific | 62 | 52 | 70 | 65 | 51 | 67 | 61 |
| Charles River Laboratories | 64 | 54 | 44 | 58 | 47 | 41 | 51 |
| ICON plc | 40 | 57 | 44 | 60 | 46 | 35 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Quest Diagnostics
- LabCorp
- BioReference Laboratories
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Quest Diagnostics | ✓ | ✓ | ✓ | ✓ | ◐ | ◐ |
| LabCorp | ◐ | ✓ | ✓ | ◐ | ✓ | ✓ |
| BioReference Laboratories | ✓ | ◐ | ◐ | ✓ | ◐ | ◐ |
| Mayo Clinic Laboratories | − | ✓ | ◐ | ✓ | − | ✓ |
| ARUP Laboratories | ✓ | ◐ | − | ✓ | ◐ | ◐ |
| Eurofins Scientific | ◐ | − | ◐ | − | ◐ | ✓ |
| Charles River Laboratories | − | ◐ | − | ◐ | − | − |
| ICON plc | − | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Quest Diagnostics88
2LabCorp84
3BioReference Laboratories74
4ARUP Laboratories67
5Mayo Clinic Laboratories65
6Eurofins Scientific61
7Charles River Laboratories51
8ICON plc47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Quest DiagnosticsLabCorp
Challenger2
Strong scale, closing on the leaders.
BioReference LaboratoriesARUP Laboratories
Contender2
Focused players with pockets of strength.
Mayo Clinic LaboratoriesEurofins Scientific
Niche2
Specialists in a single segment or region.
Charles River LaboratoriesICON plc
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Service Type in North America, then scale across Medical Toxicology Service Market — a $542M beachhead inside a $9.37B market.
Beachhead (SOM)$542Mobtainable near-term
Serviceable (SAM)$3.23Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale6 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Poison Control Center Services
Best fit — highest urgency & budget in Service Type.
Economic buyer77 fit
Clinical Toxicology Consultation
Strong fit — clear ROI and a fast path to value.
End user67 fit
Toxicology Testing and Analysis
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Service Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Toxicology Type
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel30%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Service Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Medical Toxicology Service Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified42%
Sales qualified24%
Evaluation13%
Closed-won6%
$9.8KCAC
$55KLTV
5.6:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Medical Toxicology Service Market is a durable-growth opportunity — $4.20B by 2033, compounding at 7.0%.
TAM · 2025$2.44Btoday
TAM · 2033$4.20Bforecast
CAGR7.0%2027–2033
Cumulative$29.3Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.20BTotal addressable market
SAM$1.45BServiceable available market
SOM$236MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.0% CAGR
Demand compounds through 2033, outpacing GDP across Service Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Service Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.20BLarge & growingTAM by 2033 at 7.0% CAGR
$1.45BServiceable nowreachable with today’s model
$236MBeachhead winobtainable near-term share
15+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.28BBear4.6% CAGR
$4.20BBase7.0% CAGR
$5.38BBull9.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Medical Toxicology Service Market — a $5.68B market by 2033. Plan: grow share from 8.0% to 16.3%.
Market size · 2033$5.68Btotal addressable
Market CAGR10.6%2027–2033
Target share16.3%from 8.0% today
Revenue ambition$926Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.0% | 16.3% | At risk |
| Revenue | $454M | $926M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 35.6% | 39.5% | Ahead |
| Customer retention | 85.1% | 92.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Service Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Service Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $120M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Service Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAt risk
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeBehind
- Execution & talentOn track
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Medical Toxicology Service Market conversation — a $3.57B market you can size, segment and defend in minutes.
Market size · 2033$3.57Btotal opportunity
Growth6.1%CAGR to 2033
Addressable buyers953+accounts in scope
Typical ROI7.5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Service Type
Goal Grow share in Service Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.5×return on cost, year one
< 3 mopayback period
$98K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
15+players profiled in this market
Coverage includes
Quest DiagnosticsLabCorpBioReference LaboratoriesMayo Clinic LaboratoriesARUP LaboratoriesEurofins ScientificCharles River LaboratoriesICON plc+7 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Medical Toxicology Service Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Medical Toxicology Service Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Medical Towel Sterilizer Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportMedical Tourism Treatment Services Market
Market size, share, segmentation and regional forecast.
$5.7B market · 2025 base year
View reportMedical Tourism Services Market
Market size, share, segmentation and regional forecast.
$402M market · 2025 base year
View reportMedical Touch Screen Monitor Market
Market size, share, segmentation and regional forecast.
$366M market · 2025 base year
View reportMedical Torsion Springs Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportMedical Torch Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportMedical Topical Hemostatic Agent Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportMedical Toothbrush Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportMedical Tonometer Market
Market size, share, segmentation and regional forecast.
$6.1B market · 2025 base year
View reportMedical Titanium Wire Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportMedical Titanium Rods Market
Market size, share, segmentation and regional forecast.
$1.3B market · 2025 base year
View reportMedical Titanium Mesh Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.